What top creators are saying about Lexeo Therapeutics, Inc.(LXEO)

Biotechnology company developing genetic medicines for cardiovascular and other diseases.

2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Lexeo Therapeutics, Inc. in the last 30 days yet.

Top creators covering Lexeo Therapeutics, Inc. (LXEO)

The 2 sources with the most insights about Lexeo Therapeutics, Inc. on Kazuha.

Latest insights about Lexeo Therapeutics, Inc. (LXEO)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Saturday, October 3, 2026

Slightly Bearish

A speaker found the investment interesting but also described it as a struggling position, with the share price falling from roughly $10 to $3.

Wednesday, September 30, 2026

Bearish

Mentioned as a biotech holding grouped with other negatively viewed positions, but no company-specific analysis was offered.

Discussed alongside Lexeo Therapeutics, Inc. (LXEO)

Other assets that creators frequently mention in the same content as Lexeo Therapeutics, Inc..

Frequently asked

Which podcasters and creators cover Lexeo Therapeutics, Inc. (LXEO) the most?

The most active sources covering Lexeo Therapeutics, Inc. (LXEO) on Kazuha are @realmartinshkreli, @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Lexeo Therapeutics, Inc. (LXEO) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Lexeo Therapeutics, Inc. (LXEO) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Lexeo Therapeutics, Inc. (LXEO)?

Creators covering Lexeo Therapeutics, Inc. (LXEO) most frequently also discuss NKTR, SNDK, AMD, INTC, MU. See the "Discussed alongside" section above for full asset pages.